期刊文献+

慢性心力衰竭患者血尿酸和血清胆红素异常的临床意义 被引量:8

Clinical significance of serum uric acid and serum bilirubin in patients with chronic heart failure
在线阅读 下载PDF
导出
摘要 目的探讨慢性心力衰竭(CHF)患者血尿酸(UA)和血清胆红素异常的变化及其临床意义。方法选择72例CHF患者为研究组,按心功能分级分为2组:心功能Ⅲ-Ⅳ级组41例;心功能Ⅱ级组31例。另外选取30例心功能正常者作为对照组。所有病例入院当天或第2天测定其血尿酸和血清胆红素水平,其中心功能Ⅲ-Ⅳ级患者治疗1周后复查血尿酸和血清胆红素。结果与心功能正常对照组及心功能Ⅱ级患者比较,心功能Ⅲ-Ⅳ级患者血尿酸及血清胆红素水平明显升高(P<0.01);治疗一周,心衰有效纠正后,复查血尿酸和血清胆红素水平明显下降(P<0.01)。心功能Ⅱ级患者血尿酸和血清胆红素水平与对照组比较差异无统计学意义。结论对慢性心衰患者观测血尿酸和血清胆红素水平有助于判断心衰严重程度及其治疗效果。 Objective To investigate the variational rule and clinical significance of serum uric acid and serum bilirubin in patients with chronic heart failure (CHF). Methods 72 cases with CHF were taken as study group. Among them, 41 patients with CHF classified as functional classes Ⅲ - Ⅳ of New York Heart Association (NYHA) and 31 with functional classes Ⅱ. 30 cases with normal cardiac function were taken as control group. Serum uric acid and serum bilirubin were detected on the first or second day of admission in all patients and one week later in those with functional classes Ⅲ - Ⅳ. Results The Levels of serum uric acid (UA) and serum bilirubin in patients with functional classes Ⅲ - Ⅳ were significantly higher than those with functional classes 11 and normal controls (P 〈 0.01 ). One week later, after effective treatment against CHF, the levels of UA and serum bilirubin decreased significantly (P 〈0.01 ). No differences were observed in patients with functional classes 11 and normal controls. Conclusion Dynamic observation of serum uric acid and serum bilirubin will help to evaluate the severity, therapeutic efficacy in patients with heart failure.
出处 《海南医学》 CAS 2010年第7期6-8,共3页 Hainan Medical Journal
关键词 心力衰竭 尿酸 胆红素 Heart failure Uric acid Bilirubin
  • 相关文献

参考文献7

  • 1Leyva F, Anker SD, Grodsland IF, et al. Uric acid in chronic heart failure; a maker of chrenic in flammation [J]. Eur Heart J, 1998,19 (12):1 814-1 822.
  • 2何晓薇.心力衰竭、心律失常与血清尿酸水平探讨[J].重庆医学,2005,34(3):468-468. 被引量:1
  • 3Olexa P, Olexova M, Gonsrcik J, et al. Uric acid - a maker for systemic inflammatory response in patients with congestive heart failure? [J]. wien klin wochenschr, 2002, 114(5-6):211- 215.
  • 4Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging [ J]. Circulation, 2003, 107(15): 1 991 -1 997.
  • 5程纯,吴士尧,许左隽,陈寒萼.慢性心力衰竭患者血清尿酸水平变化及临床意义[J].中国综合临床,2006,22(5):398-400. 被引量:23
  • 6Giallourakis CC, Rosenberg PM,Friedmanl S, et al. The liver in heart failure[ J]. Clin liver Dis,2002, 6:947 - 967.
  • 7Vanlingen R, Warshow U, Dalton HR ,et al. Jaundice as a presentation of heart failure[ J ]. JR Soc Med, 2005, 98:357 - 359.

二级参考文献11

  • 1Culletion BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death[J].Ann Intern Med,1999,131:7.
  • 2Puddu PE,Lanti M,Menotti A,et al.Serum acid for short-term prediction of cardiovascular disease incidence in the Gubbio population study[J].Acta Cardiol,2001,56(2):243-251.
  • 3Wannamehee SG,Shaper AG,Whincup PH.Serum urate and the risk of major coronary heart disease events[J].Heart,1997,78(5):147-153.
  • 4Anker SD,Leyva F,Poole-Wlson PA,et al.Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure[J].Heart,1997,78(1):39-43.
  • 5Culleton BF,Larson MG,Kannel WB,et al.Serum uric acid and risk for cardiovascular disease and death:the framingham heart study[J].Ann Intern Med,1999,131(1):7-13.
  • 6Freedam DS,Williamson DF,Gunter EW,et al.Relation of serum uric acid to mortality and ischemic heart disease.The nhanesi epidemiologic follow up study[J].Am J Epidemiol,1995,141(4):637-644.
  • 7Anker SD,Doehner W,Rauchhaus M,et al.Uric acid and survival in chronic heart failure[J].Circulation,2003,107(4):1 991-1 997.
  • 8Doehner W,Schoene N,Rauchhaus M,et al.Effects of xanthineoxidase inhibition with all opurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure[J].Circulation,2002,105(6):2 619-2 624.
  • 9Leyva F,Anker SD,Godsland IF,et al.Uric acid in chronic heart failure:a marker of chronic inflammation[J].Eur Heart J,1998,19(12):1 814-1 822.
  • 10何小俊,张永珍,柴红.血清尿酸水平与心血管疾病的相关性分析[J].临床心血管病杂志,2003,19(9):555-556. 被引量:21

共引文献22

同被引文献88

  • 1黄淑田,张丽娜,金露萍,尹慧娟,贾美轩.慢性心力衰竭患者肾小球滤过率、血清脑钠肽与血尿酸水平变化及其相关性研究[J].中华临床医师杂志(电子版),2011,5(23):7132-7135. 被引量:26
  • 2刘锋,张艮甫,姬西宁,黄赤兵,王平贤,范明齐.肾移植术后发生高尿酸血症的机制[J].临床泌尿外科杂志,2004,19(8):465-466. 被引量:5
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8245
  • 4甘舜进,张立新,高国旺.血清总胆红素及尿酸水平与冠状动脉病变程度的关系[J].心脏杂志,2007,19(2):246-247. 被引量:3
  • 5胡大一,马长生.心脏病学实践[M].北京:人民卫生出版社,2009:149-150.
  • 6Rosamond W, Flegal K, Friday G, et al. Heart disease and strok statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [J]. Circulation, 2007, 115(5): 169-171.
  • 7Montalcinil T, Gorgonel G, Gazzaruso C, et al. Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women [J]. Intern Emerg Med, 2007, 2(1): 19-23.
  • 8Levine W, Dyer AR, Shekelle R.B, et al. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry [J]. J Clin Epidemiol, 1989, 42(3): 257-267.
  • 9Freedman DS, Williarnson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study [J]. Am J Epidemiol, 1995, 141(7): 637-644.
  • 10Oriarty JT, Folsom AR, lribarren C, et al. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk In Communities (ARIC) study [J]. Epide-miology, 2000, 10(3): 136-143.

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部